Role of the inflammatory protein serine protease inhibitor Kazal in preventing cytolytic granule granzyme A-mediated apoptosis

Immunology

Volumn 134, Issue 4, 2011, Pages 398-408

  Lu, Felix ^a,b   Lamontagne, Jason ^a,c   Sun, Angela ^a   Pinkerton, Mark ^a,d   Block, Timothy ^a,c   Lu, Xuanyong ^a,c  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b YALE UNIVERSITY   (United States)

^c BARUCH S BLUMBERG INSTITUTE   (United States)

^d UNIVERSITY OF OKLAHOMA   (United States)

Author keywords

Apoptosis; Cancer; Granzyme A; Inflammation; Serine protease inhibitor Kazal

Indexed keywords

APROTININ; GRANZYME A;

APOPTOSIS; ARTICLE; CANCER CELL; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOSURVEILLANCE; PRIORITY JOURNAL; PROTEIN FUNCTION;

ANTIBODIES, MONOCLONAL; APOPTOSIS; CELL LINE; GRANZYMES; HUMANS; IMMUNOLOGIC SURVEILLANCE; IMMUNOPRECIPITATION; IMMUNOTHERAPY; KILLER CELLS, NATURAL; NEOPLASMS; T-LYMPHOCYTES, CYTOTOXIC; TRYPSIN INHIBITOR, KAZAL PANCREATIC; TUMOR ESCAPE;

EID: 80355144177     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2011.03498.x     Document Type: Article

References (34)

1. Stenman UH. Tumor-associated trypsin inhibitor. Clin Chem 2002; 48:1206-9.
2. Greene LJ. Pancreatic exocrine secretory proteins. J Surg Oncol 1975; 7:151-4.
3. Higashiyama M, Monden T, Tomita N et al. Expression of pancreatic secretory trypsin inhibitor (PSTI) in colorectal cancer. Br J Cancer 1990; 62:954-8.
4. Tomita N, Doi S, Higashiyama M et al. Expression of pancreatic secretory trypsin inhibitor gene in human colorectal tumor. Cancer 1990; 66:2144-9.
5. Ohmachi Y, Murata A, Matsuura N et al. Specific expression of the pancreatic-secretory-trypsin-inhibitor (PSTI) gene in hepatocellular carcinoma. Int J Cancer 1993; 55:728-34.
6. Lukkonen A, Lintula S, von Boguslawski K et al. Tumor-associated trypsin inhibitor in normal and malignant renal tissue and in serum of renal-cell carcinoma patients. Int J Cancer 1999; 83:486-90.
7. Tonouchi A, Ohtsuka M, Ito H et al. Relationship between pancreatic secretory trypsin inhibitor and early recurrence of intrahepatic cholangiocarcinoma following surgical resection. Am J Gastroenterol 2006; 101:1601-10.
8. Lee YC, Pan HW, Peng SY et al. Overexpression of tumour-associated trypsin inhibitor (TATI) enhances tumour growth and is associated with portal vein invasion, early recurrence and a stage-independent prognostic factor of hepatocellular carcinoma. Eur J Cancer 2007; 43:736-44.
9. Ogawa M, Shibata T, Niinobu T, Uda K, Takata N, Mori T. Serum pancreatic secretory trypsin inhibitor (PSTI) in patients with inflammatory diseases. Adv Exp Med Biol 1988; 240:505-8.
10. Witt H, Luck W, Hennies HC et al. Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis. Nat Genet 2000; 25:213-6.
11. Cavestro GM, Zuppardo RA, Bertolini S et al. Connections between genetics and clinical data: role of MCP-1, CFTR, and SPINK-1 in the setting of acute, acute recurrent, and chronic pancreatitis. Am J Gastroenterol 2010; 105:199-206.
12. Uda K-I, Murata A, Nishijima J-I et al. Elevation of circulating monitor peptide/pancreatic secretory trypsin inhibitor-I (PSTI-61) after turpentine-induced inflammation in rats: hepatocytes produce it as an acute phase reactant. J Surg Res 1994; 57:563-8.
13. Greene LJ, Pubols MH, Bartelt DC. Human pancreatic secretory trypsin inhibitor. Methods Enzymol 1976; 45:813-25.
14. Lamontagne J, Pinkerton M, Block TM, Lu X. Hepatitis B and hepatitis C virus replication upregulates serine protease inhibitor Kazal, resulting in cellular resistance to serine protease-dependent apoptosis. J Virol 2010; 84:907-17.
15. Wiksten JP, Lundin J, Nordling S, Kokkola A, Stenman UH, Haglund C. High tissue expression of tumour-associated trypsin inhibitor (TATI) associates with a more favourable prognosis in gastric cancer. Histopathology 2005; 46:380-8.
16. Gaber A, Nodin B, Hotakainen K et al. Increased serum levels of tumour-associated trypsin inhibitor independently predict a poor prognosis in colorectal cancer patients. BMC Cancer 2010; 10:498.
17. Chisari FV. Cytotoxic T cells and viral hepatitis. J Clin Invest 1997; 99:1472-7.
18. Chisari FV, Ferrari C. Hepatitis B virus immunopathogenesis. Annu Rev Immunol 1995; 13:29-60.
19. Guicciardi ME, Gores GJ. Apoptosis: a mechanism of acute and chronic liver injury. Gut 2005; 54:1024-33.
20. Kerr JF, Winterford CM, Harmon BV. Apoptosis. Its significance in cancer and cancer therapy. Cancer 1994; 73:2013-26.
21. Pardo J, Balkow S, Anel A, Simon MM. Granzymes are essential for natural killer cell-mediated and perf-facilitated tumor control. Eur J Immunol 2002; 32:2881-7.
22. Pardo J, Aguilo JI, Anel A et al. The biology of cytotoxic cell granule exocytosis pathway: granzymes have evolved to induce cell death and inflammation. Microbes Infect 2009; 11:452-9.
23. Tsuzuki S, Kokado Y, Satomi S et al. Purification and identification of a binding protein for pancreatic secretory trypsin inhibitor: a novel role of the inhibitor as an anti-granzyme A. Biochem J 2003; 1:227-33.
24. Pardo J, Simon MM, Froelich CJ. Granzyme A is a proinflammatory protease. Blood 2009; 114:3968; author reply 3969-70.
25. Metkar SS, Menaa C, Pardo J et al. Human and mouse granzyme A induce a proinflammatory cytokine response. Immunity 2008; 29:720-33.
26. Martinvalet D, Zhu P, Lieberman J. Granzyme A induces caspase-independent mitochondrial damage, a required first step for apoptosis. Immunity 2005; 22:355-70.
27. Lieberman J. Granzyme A activates another way to die. Immunol Rev 2010; 235:93-104.
28. Lu X, Lamontagne J, Lu F, Block T. Tumor-associated protein SPIK/TATI suppresses serine protease dependent cell apoptosis. Apoptosis 2008; 13:483-94.
29. Lu X, Block T. Study of the early steps of the hepatitis B virus life cycle. Int J Med Sci 2004; 1:21-33.
30. Bartelt DC, Shapanka R, Greene LJ. The primary structure of the human pancreatic secretory trypsin inhibitor. Amino acid sequence of the reduced S-aminoethylated protein. Arch Biochem Biophys 1977; 179:189-99.
31. Trapani JA, Smyth MJ. Functional significance of the perforin/granzyme cell death pathway. Nat Rev Immunol 2002; 2:735-47.
32. Boulling A, Le Marechal C, Trouve P, Raguenes O, Chen J-M, Ferec C. Functional analysis of pancreatitis-associated missense mutations in the pancreatic secretory trypsin inhibitor (SPINK1) gene. Eur J Hum Genet 2007; 15:936-42.
33. Lieberman J, Fan Z. Nuclear war: the granzyme A-bomb. Curr Opin Immunol 2003; 15:553-9.
34. Cullen SP, Brunet M, Martin SJ. Granzymes in cancer and immunity. Cell Death Differ 2010; 17:616-23.